Fresno Cancer Center — Fresno, California

Public research footprint of Fresno Cancer Center, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Breast Cancer · Stage III Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8 · Recurrent Ovarian Carcinoma · Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal…

Recently updated registry entries

NCT03258554 — Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally… (Completed)
NCT02839707 — Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in… (Active Not Recruiting)
NCT02152982 — Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Fresno Cancer Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.